文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

草药联合纳米医学在癌症方面的最新进展:给药技术和治疗效果。

Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes.

机构信息

Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Arab Academy for Science Technology & Maritime Transport, Alexandria, Egypt.

Cancer Nanotechnology Research Laboratory (CNRL), Faculty of Pharmacy, Alexandria University, Alexandria, Egypt.

出版信息

Expert Opin Drug Deliv. 2021 Nov;18(11):1609-1625. doi: 10.1080/17425247.2021.1955853. Epub 2021 Aug 4.


DOI:10.1080/17425247.2021.1955853
PMID:34254868
Abstract

: The use of herbal compounds in cancer therapy has great potential to promote the efficacy of current cancer therapeutic strategies. Herbal compounds were successfully reported to enhance tumor cells sensitization to the action of chemo-, hormonal- and gene-therapeutic agents different mechanisms. Herbal ingredients can affect different signaling pathways, reduce the toxic side effects or inhibit the efflux of anticancer drugs.: This review will discuss the delivery of herbal compounds with other cancer treatments such as hormonal, small molecule inhibitors and inorganic hybrids to tumor cells. An overview of physicochemical properties of herbal components that require intelligent design of combo-nanomedicines for efficient co-delivery of those herbal-derived and other anticancer agents was discussed. Nanocarriers provide various benefits to overcome the shortcomings of the encapsulated herbal compounds including improved solubility, increased stability and enhanced tumor targeting. Different nanocarrier systems were the focus of this review.: Multifunctional nanocarrier systems encapsulating herbal and different anticancer drugs showed to be a wonderful approach in the treatment of cancer enabling the co-delivery of anticancer drugs with versatile modes of action in an accurate manner in an attempt to enhance the efficacy, benefit from the synergism between the drugs as well as to minimize the development of multi-drug resistance. The main challenge point is the early detection and management of any developed adverse effect.

摘要

草药化合物在癌症治疗中的应用具有很大的潜力,可以提高当前癌症治疗策略的疗效。已经有报道称,草药化合物成功地增强了肿瘤细胞对化疗、激素和基因治疗药物的敏感性,其作用机制各不相同。草药成分可以影响不同的信号通路,减少抗癌药物的毒副作用或抑制其外排。

本综述将讨论将草药化合物与其他癌症治疗方法(如激素、小分子抑制剂和无机杂化物)一起递送至肿瘤细胞的方法。概述了草药成分的物理化学性质,这些性质需要对组合纳米药物进行智能设计,以有效地共递输送草药衍生的和其他抗癌药物。纳米载体提供了多种益处,可克服包裹的草药化合物的缺点,包括提高溶解度、增加稳定性和增强肿瘤靶向性。不同的纳米载体系统是本综述的重点。

多官能纳米载体系统可以同时封装草药和不同的抗癌药物,这是一种治疗癌症的好方法,可以精确地共递输送具有多种作用机制的抗癌药物,以提高疗效、从药物协同作用中获益,并最大限度地减少多药耐药性的产生。主要的挑战点是早期发现和管理任何已开发的不良反应。

相似文献

[1]
Recent advances in herbal combination nanomedicine for cancer: delivery technology and therapeutic outcomes.

Expert Opin Drug Deliv. 2021-11

[2]
Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment.

Adv Drug Deliv Rev. 2022-9

[3]
Nanomedicines as emerging platform for simultaneous delivery of cancer therapeutics: new developments in overcoming drug resistance and optimizing anticancer efficacy.

Artif Cells Nanomed Biotechnol. 2018-6-6

[4]
Nanomedicine-based combination anticancer therapy between nucleic acids and small-molecular drugs.

Adv Drug Deliv Rev. 2017-6-15

[5]
Anticancer nanomedicines harnessing tumor microenvironmental components.

Expert Opin Drug Deliv. 2022-4

[6]
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.

ACS Nano. 2020-10-27

[7]
Nanocarriers overcoming biological barriers induced by multidrug resistance of chemotherapeutics in 2D and 3D cancer models.

Drug Resist Updat. 2023-5

[8]
Aptamer-guided nanomedicines for anticancer drug delivery.

Adv Drug Deliv Rev. 2018-9-27

[9]
Combination antitumor therapy with targeted dual-nanomedicines.

Adv Drug Deliv Rev. 2017-3-7

[10]
Unraveling the role of Intralipid in suppressing off-target delivery and augmenting the therapeutic effects of anticancer nanomedicines.

Acta Biomater. 2021-5

引用本文的文献

[1]
Co-delivery of Exemestane and Genistein via Chitosan Coated Liposomes for Enhanced Antitumor Effect and Bone Loss Prevention in Breast Cancer Therapy: In Vivo Evaluation.

AAPS PharmSciTech. 2025-6-27

[2]
An Updated Review of Molecular Mechanisms Implicated with the Anticancer Potential of Diosgenin and Its Nanoformulations.

Drug Des Devel Ther. 2025-3-24

[3]
Modulation of miR-205 expression using a phyto-nano hybrid as a potential therapeutic agent against breast cancer.

RSC Adv. 2024-11-21

[4]
Temporin-GHaK Exhibits Antineoplastic Activity against Human Lung Adenocarcinoma by Inhibiting the Wnt Signaling Pathway through miRNA-4516.

Molecules. 2024-6-12

[5]
Shenqi Fuzheng injection hinders non-small cell lung cancer cell growth by regulating the Bax/Bcl-2 signaling pathway.

Discov Oncol. 2024-5-29

[6]
Herbal Theranostics: Controlled, Targeted Delivery and Imaging of Herbal Molecules.

Nanotheranostics. 2024

[7]
Nanoparticles loaded with natural medicines for the treatment of Alzheimer's disease.

Front Neurosci. 2023-10-9

[8]
pH-sensitive liposomes bearing a chemotherapeutic agent and a natural apoptosis modulator for effective intracellular delivery to the solid tumor.

Drug Deliv Transl Res. 2023-12

[9]
Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook.

Heliyon. 2023-5-24

[10]
Dimethylaminoethyl Methacrylate/Diethylene Glycol Dimethacrylate Grafted onto Folate-Esterified Bagasse Xylan/Andrographolide Composite Nanoderivative: Synthesis, Molecular Docking and Biological Activity.

Molecules. 2022-9-14

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索